Acute exacerbation of COPD (severe)
Bedside summary
An acute COPD exacerbation is a sustained WORSENING of respiratory symptoms — increased DYSPNOEA, increased SPUTUM VOLUME, and increased SPUTUM PURULENCE (the three Anthonisen cardinal symptoms) — beyond normal day-to-day variation, needing a change in treatment. Most are triggered by respiratory infection (viral or bacterial) or air-pollutant exposure. The danger is progressive type 2 (hypercapnic) respiratory failure with a respiratory acidosis. Assessment is CLINICAL and physiological — there is no single confirmatory test — and the key early decision is whether the patient has a compensated flare or is heading for ventilatory failure.
Red flags
- Rising PaCO₂ with a falling pH (worsening respiratory acidosis) despite therapy
- Exhaustion, drowsiness/confusion (CO₂ narcosis), or a silent chest
- Severe hypoxaemia, haemodynamic instability, or new arrhythmia
- Failure to improve on controlled oxygen + nebulisers — escalate to NIV early
Assessment
Investigations
- ARTERIAL BLOOD GAS is central — it defines type 1 vs type 2 failure and detects a respiratory ACIDOSIS (low pH, high PaCO₂) that drives the need for NIV
- Chest X-ray — look for pneumonia, pneumothorax, effusion or pulmonary oedema (alternative/added diagnosis)
- ECG and consider troponin/BNP (cardiac comorbidity, cor pulmonale, arrhythmia)
- FBC, U&E, CRP; sputum culture if purulent/failing therapy; and always EXCLUDE PE and heart failure, which mimic and coexist with exacerbations
Complications & pitfalls
- Type 2 respiratory failure and respiratory acidosis (may need NIV, then intubation)
- Pneumonia, pneumothorax, pulmonary embolism
- Cor pulmonale / right-heart failure and arrhythmias (e.g. AF, multifocal atrial tachycardia)
- Oxygen-induced hypercapnia if uncontrolled high-flow O₂ is given to a CO₂ retainer
Exam pearls
- The three cardinal (Anthonisen) symptoms — more breathlessness, more sputum, more purulent sputum — define the exacerbation and guide antibiotic use (antibiotics benefit most when sputum is purulent or the patient needs ventilatory support).
- TITRATE oxygen to a target SpO₂ of 88–92% in patients at risk of hypercapnia (use a 24–28% Venturi / controlled device) — the goal is to correct hypoxaemia without abolishing respiratory drive.
- Cornerstone drug therapy: nebulised SHORT-ACTING bronchodilators (salbutamol + ipratropium), SYSTEMIC CORTICOSTEROIDS (e.g. prednisolone 30–40 mg for ~5 days), and ANTIBIOTICS for infective (purulent) exacerbations.
- Start NIV (bilevel) for a persistent respiratory acidosis (pH < 7.35 with PaCO₂ high) despite optimal medical therapy — it reduces intubation and mortality; escalate to intubation if NIV fails or is contraindicated.
- Always look for a precipitant/mimic — pneumonia, pneumothorax, PE, heart failure, arrhythmia — and treat it.
Treat a severe COPD exacerbation with CONTROLLED oxygen to 88–92%, nebulised salbutamol + ipratropium, systemic corticosteroids (~5 days) and antibiotics for purulent/infective flares; do a blood gas early and start NIV for a persistent respiratory acidosis (pH < 7.35) — escalate to intubation if NIV fails. Exclude and treat mimics (pneumonia, PE, pneumothorax, heart failure).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.